Seeking Alpha

INSM
  Insmed, Inc. - NASDAQ

8/22/2014, 3:57 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
INSM vs. ETF Alternatives
Company Description
Insmed, Inc. is a biopharmaceutical company engaged in developing and commercializing inhaled therapies for patients battling serious lung diseases that are often life threatening. Its lead product candidate is ARIKAYCE.
Sector: Healthcare
Industry: Biotechnology
Country: United States